![logo](/logos/002349.SZ.webp)
Jinghua Pharmaceutical Group Co., Ltd.
SZSE:002349.SZ
8.74 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1,490.447 | 1,573.06 | 1,357.868 | 1,281.353 | 1,157.389 | 1,354.706 | 1,120.92 | 881.487 | 780.334 | 577.754 | 732.618 | 665.382 | 375.502 | 274.32 | 259.387 | 234.869 | 229.554 | 209.836 |
Cost of Revenue
| 797.492 | 837.915 | 725.685 | 662.32 | 631.158 | 703.911 | 561.858 | 443.814 | 479.698 | 354.482 | 521.655 | 470.9 | 230.321 | 133.394 | 133.372 | 128.612 | 129.563 | 127.48 |
Gross Profit
| 692.955 | 735.145 | 632.183 | 619.033 | 526.232 | 650.795 | 559.062 | 437.673 | 300.636 | 223.271 | 210.963 | 194.482 | 145.181 | 140.926 | 126.014 | 106.257 | 99.991 | 82.356 |
Gross Profit Ratio
| 0.465 | 0.467 | 0.466 | 0.483 | 0.455 | 0.48 | 0.499 | 0.497 | 0.385 | 0.386 | 0.288 | 0.292 | 0.387 | 0.514 | 0.486 | 0.452 | 0.436 | 0.392 |
Reseach & Development Expenses
| 59.383 | 86.98 | 74.758 | 52.053 | 82.755 | 40.319 | 37.667 | 42.941 | 26.639 | 15.713 | 11.868 | 10.56 | 11.127 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 32.316 | 40.319 | 37.792 | 43.493 | 33.229 | 33.413 | 35.792 | 23.595 | 22.269 | 18.296 | 20.399 | 14.348 | 8.146 | 37.145 | 32.733 | 30.503 | 30.587 | 29.466 |
Selling & Marketing Expenses
| 227.973 | 252.118 | 215.02 | 177.084 | 174.943 | 169.038 | 140.888 | 116.085 | 104.794 | 89.52 | 79.324 | 72.636 | 57.479 | 50.91 | 49.781 | 36.975 | 30.057 | 27.06 |
SG&A
| 332.193 | 292.437 | 252.812 | 220.577 | 208.172 | 202.451 | 176.68 | 139.68 | 127.063 | 107.816 | 99.723 | 86.983 | 65.625 | 88.055 | 82.514 | 67.478 | 60.644 | 56.526 |
Other Expenses
| -5.442 | 120.266 | 112.987 | 94.464 | 100.302 | -5.005 | 45.924 | 8.497 | 3.956 | 11.295 | 12.817 | 28.315 | 18.705 | 1.353 | -0.451 | 0.265 | 6.139 | -0.461 |
Operating Expenses
| 397.018 | 499.682 | 440.556 | 367.093 | 391.229 | 332.1 | 285.237 | 261.571 | 212.278 | 175.598 | 160.298 | 146.62 | 104.929 | 90.931 | 85.629 | 69.881 | 63.121 | 58.696 |
Operating Income
| 295.937 | 251.484 | 180.505 | 269.228 | 145.876 | 293.472 | 170.897 | 193.689 | 92.989 | 39.842 | 39.247 | 43.893 | 38.49 | 48.927 | 39.527 | 31.602 | 33.066 | 17.982 |
Operating Income Ratio
| 0.199 | 0.16 | 0.133 | 0.21 | 0.126 | 0.217 | 0.152 | 0.22 | 0.119 | 0.069 | 0.054 | 0.066 | 0.103 | 0.178 | 0.152 | 0.135 | 0.144 | 0.086 |
Total Other Income Expenses Net
| 35.014 | -1.271 | -1.618 | -205.483 | -646.536 | -30.228 | -57.004 | 25.883 | 8.366 | 3.417 | -7.841 | 24.235 | 16.924 | 0.188 | -1.309 | -4.509 | 1.99 | -6.386 |
Income Before Tax
| 330.951 | 250.213 | 178.887 | 63.745 | -500.66 | 288.467 | 216.821 | 201.985 | 96.724 | 51.09 | 42.824 | 72.097 | 57.176 | 50.184 | 39.076 | 31.867 | 38.86 | 17.274 |
Income Before Tax Ratio
| 0.222 | 0.159 | 0.132 | 0.05 | -0.433 | 0.213 | 0.193 | 0.229 | 0.124 | 0.088 | 0.058 | 0.108 | 0.152 | 0.183 | 0.151 | 0.136 | 0.169 | 0.082 |
Income Tax Expense
| 53.229 | 37.917 | 38.928 | 35.82 | 23.689 | 28.397 | 26.495 | 28.526 | 14.882 | 10.463 | 2.151 | 12.48 | 8.825 | 7.544 | 6.276 | 5.703 | 13.266 | 5.472 |
Net Income
| 247.697 | 212.225 | 160.702 | 27.925 | -524.349 | 229.665 | 175.32 | 165.03 | 78.081 | 39.468 | 35.597 | 49.223 | 48.102 | 42.639 | 32.8 | 26.163 | 25.593 | 11.802 |
Net Income Ratio
| 0.166 | 0.135 | 0.118 | 0.022 | -0.453 | 0.17 | 0.156 | 0.187 | 0.1 | 0.068 | 0.049 | 0.074 | 0.128 | 0.155 | 0.126 | 0.111 | 0.111 | 0.056 |
EPS
| 0.3 | 0.26 | 0.2 | 0.034 | -0.64 | 0.28 | 0.21 | 0.2 | 0.1 | 0.066 | 0.059 | 0.082 | 0.08 | 0.073 | 0.073 | 0.058 | 0.057 | 0.027 |
EPS Diluted
| 0.3 | 0.26 | 0.2 | 0.034 | -0.64 | 0.28 | 0.21 | 0.2 | 0.1 | 0.066 | 0.059 | 0.082 | 0.08 | 0.073 | 0.073 | 0.058 | 0.057 | 0.027 |
EBITDA
| 372.17 | 390.425 | 304.235 | 353.221 | 227.247 | 404.597 | 387.301 | 264.87 | 158.126 | 102.946 | 87.09 | 97.292 | 70.844 | 60.036 | 49.625 | 46.267 | 53.369 | 40.116 |
EBITDA Ratio
| 0.25 | 0.248 | 0.224 | 0.276 | 0.196 | 0.299 | 0.346 | 0.3 | 0.203 | 0.178 | 0.119 | 0.146 | 0.189 | 0.219 | 0.191 | 0.197 | 0.232 | 0.191 |